CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Sell
25
CHX Quote, Financials, Valuation and Earnings
Last price:
$24.32
Seasonality move
:
1.86%
Day range:
$24.09 - $24.52
52-week range:
$21.92 - $35.94
Dividend yield:
1.56%
P/E ratio:
16.13x
P/S ratio:
1.32x
P/B ratio:
2.43x
Volume:
5.2M
Avg. volume:
6.4M
1-year change:
-28.62%
Market cap:
$4.7B
Revenue:
$3.6B
EPS (TTM):
$1.51
Analysts' Opinion
-
Consensus RatingChampionX has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $43.60, ChampionX has an estimated upside of 78.98% from its current price of $24.29.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $35.00 representing -43.68% downside risk from its current price of $24.29.
Fair Value
-
According to the consensus of 3 analysts, ChampionX has 78.98% upside to fair value with a price target of $43.60 per share.
CHX vs. S&P 500
-
Over the past 5 trading days, ChampionX has underperformed the S&P 500 by -1.31% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
ChampionX does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ChampionX revenues have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter ChampionX reported revenues of $864.5M.
Earnings Growth
-
ChampionX earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter ChampionX reported earnings per share of $0.44.
Enterprise value:
4.7B
EV / Invested capital:
1.89x
Price / LTM sales:
1.32x
EV / EBIT:
10.21x
EV / Revenue:
1.32x
PEG ratio (5yr expected):
2.87x
EV / Free cash flow:
13.79x
Price / Operating cash flow:
13.77x
Enterprise value / EBITDA:
6.66x
Gross Profit (TTM):
$1.2B
Return On Assets:
8.64%
Net Income Margin (TTM):
8.2%
Return On Equity:
16.36%
Return On Invested Capital:
12.26%
Operating Margin:
13.24%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $3.9B | $3.7B | $3.6B | $922.1M | $864.5M | |
| Gross Profit | $974.4M | $1.2B | $1.2B | $299.2M | $291.5M | |
| Operating Income | $371.7M | $510.9M | $455.8M | $126.8M | $114.5M | |
| EBITDA | $531.3M | $766.6M | $709M | $213.3M | $177.7M | |
| Diluted EPS | $0.88 | $1.84 | $1.51 | $0.58 | $0.44 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.3B | $1.5B | $1.5B | $1.5B | $1.8B | |
| Total Assets | $3.5B | $3.6B | $3.3B | $3.3B | $3.5B | |
| Current Liabilities | $632.4M | $831.9M | $841M | $807.2M | $784.9M | |
| Total Liabilities | $1.8B | $1.8B | $1.7B | $1.6B | $1.6B | |
| Total Equity | $1.6B | $1.8B | $1.7B | $1.7B | $1.9B | |
| Total Debt | $926.3M | $718.1M | $602.2M | $599.8M | $596.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $548.9M | $621.4M | $483M | $173.5M | $66.8M | |
| Cash From Investing | -$90M | -$115.5M | -$232.8M | -$10.8M | -$28.2M | |
| Cash From Financing | -$386.1M | -$366.2M | -$106.5M | -$64.1M | -$20.1M | |
| Free Cash Flow | $450.1M | $473.7M | $342.3M | $141.6M | $35.6M | |
CHX
Sector
Market Cap
$4.7B
$59.1M
Price % of 52-Week High
67.78%
58.05%
Dividend Yield
1.56%
0%
Shareholder Yield
1.29%
4.8%
1-Year Price Total Return
-27.84%
-31.82%
Beta (5-Year)
1.523
0.682
Dividend yield:
1.56%
Annualized payout:
$0.37
Payout ratio:
24.7%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$24.56
200-day SMA
Sell
Level
$29.38
Bollinger Bands (100)
Sell
Level
25.7 - 29.96
Chaikin Money Flow
Buy
Level
111.7M
20-day SMA
Sell
Level
$24.68
Relative Strength Index (RSI14)
Sell
Level
41.19
ADX Line
Sell
Level
19.03
Williams %R
Neutral
Level
-62.1176
50-day SMA
Sell
Level
$27.09
MACD (12, 26)
Sell
Level
-0.72
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Neutral
Level
101.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.5921)
Buy
CA Score
(Annual)
Level (0.7445)
Buy
Beneish M-Score
(Annual)
Level (-2.9991)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.2975)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.
Stock Forecast FAQ
In the current month, CHX has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CHX average analyst price target in the past 3 months is $43.60.
-
Where Will ChampionX Stock Be In 1 Year?
According to analysts, the consensus estimate is that ChampionX share price will rise to $43.60 per share over the next 12 months.
-
What Do Analysts Say About ChampionX?
Analysts are divided on their view about ChampionX share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ChampionX is a Sell and believe this share price will drop from its current level to $35.00.
-
What Is ChampionX's Price Target?
The price target for ChampionX over the next 1-year time period is forecast to be $43.60 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CHX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ChampionX is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CHX?
You can purchase shares of ChampionX via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ChampionX shares.
-
What Is The ChampionX Share Price Today?
ChampionX was last trading at $24.32 per share. This represents the most recent stock quote for ChampionX. Yesterday, ChampionX closed at $24.29 per share.
-
How To Buy ChampionX Stock Online?
In order to purchase ChampionX stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
